Investors

Investors
<picture><source type="image/webp" srcSet="/static/0516a9494478ba52976383cbc6341adf/cf507/new-event-3.webp 840w,/static/0516a9494478ba52976383cbc6341adf/4c73b/new-event-3.webp 1680w,/static/0516a9494478ba52976383cbc6341adf/5b327/new-event-3.webp 3360w" sizes="(min-width: 3360px) 3360px, 100vw"/><img data-gatsby-image-ssr="" data-main-image="" style="opacity:0" sizes="(min-width: 3360px) 3360px, 100vw" decoding="async" loading="lazy" src="/static/0516a9494478ba52976383cbc6341adf/1e00c/new-event-3.jpg" srcSet="/static/0516a9494478ba52976383cbc6341adf/f86f7/new-event-3.jpg 840w,/static/0516a9494478ba52976383cbc6341adf/1d57d/new-event-3.jpg 1680w,/static/0516a9494478ba52976383cbc6341adf/1e00c/new-event-3.jpg 3360w" alt="&lt;p&gt;Image of a middle aged man dressed in a blazer, clapping his hands while smiling.&lt;/p&gt;
"/></picture>
Welcome to the Mendus investor page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU. 

Overview
Press releases
Events
Corporate Governance
Articles of Association
General meetings
Board of Directors
Corporate governance reports
Nomination committee
Remuneration and the remuneration committee
Auditors and audit committee
Scientific committee
Shareholder & stock info
Share monitor
Shareholders
Analyst coverage
Financial reports
Financial calendar
Transactions
Reverse share split (2024)
Rights Issue and Directed Issue (2023)
Archive
CEO Commentary: 
Building momentum across myeloid blood cancersTo read the latest CEO comment, please click here.
Corporate presentation Please find below the latest corporate presentation
<img data-gatsby-image-ssr="" data-wp-inline-image="1" data-main-image="" style="height:100%;left:0;position:absolute;top:0;transform:translateZ(0);transition:opacity 250ms linear;width:100%;will-change:opacity;opacity:0" sizes="(min-width: 1024px) 1024px, 100vw" decoding="async" loading="lazy" src="/_gatsby/image/20c216e27ef5cbe82b4913d062b8fc00/2e45081cb07f0df31004154cf1e22444/Corporate-Presentation-image.jpg?u=https%3A%2F%2Fmendus-uploads-prod.s3.amazonaws.com%2Fuploads%2F2026%2F08%2FCorporate-Presentation-image.jpg&amp;a=w%3D256%26h%3D144%26fm%3Djpg%26q%3D90&amp;cd=2026-08-20T09%3A23%3A04" srcSet="/_gatsby/image/20c216e27ef5cbe82b4913d062b8fc00/2e45081cb07f0df31004154cf1e22444/Corporate-Presentation-image.jpg?u=https%3A%2F%2Fmendus-uploads-prod.s3.amazonaws.com%2Fuploads%2F2026%2F08%2FCorporate-Presentation-image.jpg&amp;a=w%3D256%26h%3D144%26fm%3Djpg%26q%3D90&amp;cd=2026-08-20T09%3A23%3A04 256w,/_gatsby/image/20c216e27ef5cbe82b4913d062b8fc00/96b647ec7d907c05daf79ebbaf49d64f/Corporate-Presentation-image.jpg?u=https%3A%2F%2Fmendus-uploads-prod.s3.amazonaws.com%2Fuploads%2F2026%2F08%2FCorporate-Presentation-image.jpg&amp;a=w%3D512%26h%3D288%26fm%3Djpg%26q%3D90&amp;cd=2026-08-20T09%3A23%3A04 512w,/_gatsby/image/20c216e27ef5cbe82b4913d062b8fc00/445de7002b86e33254a5db750f4f2f35/Corporate-Presentation-image.jpg?u=https%3A%2F%2Fmendus-uploads-prod.s3.amazonaws.com%2Fuploads%2F2026%2F08%2FCorporate-Presentation-image.jpg&amp;a=w%3D1024%26h%3D576%26fm%3Djpg%26q%3D90&amp;cd=2026-08-20T09%3A23%3A04 1024w" alt=""/>
 

Contact
Telephone+46 (0)8 732 8400
Emailinfo@mendus.com
<picture><source type="image/webp" srcSet="/static/411b7857055b0888002108e1bcc9e280/e64f1/heado.webp 100w,/static/411b7857055b0888002108e1bcc9e280/8b00d/heado.webp 200w,/static/411b7857055b0888002108e1bcc9e280/9c0a1/heado.webp 400w,/static/411b7857055b0888002108e1bcc9e280/88f3e/heado.webp 800w" sizes="(min-width: 400px) 400px, 100vw"/><img data-gatsby-image-ssr="" data-main-image="" style="opacity:0" sizes="(min-width: 400px) 400px, 100vw" decoding="async" loading="lazy" src="/static/411b7857055b0888002108e1bcc9e280/10998/heado.jpg" srcSet="/static/411b7857055b0888002108e1bcc9e280/93e3f/heado.jpg 100w,/static/411b7857055b0888002108e1bcc9e280/839ae/heado.jpg 200w,/static/411b7857055b0888002108e1bcc9e280/10998/heado.jpg 400w,/static/411b7857055b0888002108e1bcc9e280/a677a/heado.jpg 800w" alt="&lt;p&gt;Image of old buildings by a dock with boats laying in the water in the foreground.&lt;/p&gt;
"/></picture>
Head OfficeVästra Trädgårdsgatan 15

111 53 Stockholm

Sweden
<picture><source type="image/webp" srcSet="/static/99d97027eda87168e92d8d30678ace5b/e64f1/rdo.webp 100w,/static/99d97027eda87168e92d8d30678ace5b/8b00d/rdo.webp 200w,/static/99d97027eda87168e92d8d30678ace5b/9b01d/rdo.webp 400w,/static/99d97027eda87168e92d8d30678ace5b/08dc5/rdo.webp 800w" sizes="(min-width: 400px) 400px, 100vw"/><img data-gatsby-image-ssr="" data-main-image="" style="opacity:0" sizes="(min-width: 400px) 400px, 100vw" decoding="async" loading="lazy" src="/static/99d97027eda87168e92d8d30678ace5b/fa758/rdo.jpg" srcSet="/static/99d97027eda87168e92d8d30678ace5b/93e3f/rdo.jpg 100w,/static/99d97027eda87168e92d8d30678ace5b/839ae/rdo.jpg 200w,/static/99d97027eda87168e92d8d30678ace5b/fa758/rdo.jpg 400w,/static/99d97027eda87168e92d8d30678ace5b/3f065/rdo.jpg 800w" alt="&lt;p&gt;City image from a walkway, with a church and tall buildings in the background.&lt;/p&gt;
"/></picture>
R&D OfficesEmmy Noetherweg 2K 

2333 BK Leiden

The Netherlands

CEO Commentary: Building momentum across myeloid blood cancers

Corporate presentation

Contact

Telephone

Email

Head Office

R&D Offices

CEO Commentary:
Building momentum across myeloid blood cancers